1. Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran∗). part I. absolute bioavailability of 0.25 mg of ganirelix after a single subcutaneous injection in healthy female volunteers 
Janine J.L Oberyé, Bernadette M.J.L Mannaerts, Huub-Jan Kleijn, B.Sc., Cees J Timmer 
Fertility and Sterility 
Volume 72, Issue 6, Pages (December 1999)
DOI: /S (99)

2. Figure 1
Log-linear plot of serum ganirelix concentrations after SC administration and IV administration of 0.25 mg of ganirelix to 15 healthy female volunteers.
Oberyé. Ganirelix (Antagon/Orgalutran). Fertil Steril 1999.
Fertility and Sterility  , DOI: ( /S (99) )

3. Figure 2
Systolic and diastolic blood pressure after SC administration (n = 18) and IV administration (n = 17) of 0.25 mg of ganirelix to healthy female volunteers. ▴ = systolic (IV); ▵ = systolic (SC); • = diastolic (IV); ○ = diastolic (SC).
Oberyé. Ganirelix (Antagon/Orgalutran). Fertil Steril 1999.
Fertility and Sterility  , DOI: ( /S (99) )